12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301 — Paramount, California

12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301 is a clinical research site located in Paramount, California, United States 90723.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301 has participated in 1 clinical trials.

Therapeutic areas: Meningitis, Meningococcal Infection.

Sponsors: Novartis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Paramount

Browse all research sites in California · View every site in Paramount

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301?

12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301 conducted?

12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301 has 1 clinical trials on record. Their work covers Meningitis, Meningococcal Infection.

Is 12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301 accredited by Crixeo Clinical Trials?

12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 12 Center For Clinical Trials, LLC. 16660 Paramount Blvd Suite 301?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.